Substituted quinolines as noncovalent proteasome inhibitors

Murata, 2009, Nat. Rev. Mol. Cell Biol., 10, 104, 10.1038/nrm2630 Groll, 2004, Biochim. Biophys. Acta, 1695, 33, 10.1016/j.bbamcr.2004.09.025 Ben-Nissan, 2014, Biomolecules, 4, 862, 10.3390/biom4030862 Groll, 1999, Proc. Natl. Acad. Sci. U.S.A., 96, 10976, 10.1073/pnas.96.20.10976 Groll, 1997, Nature, 386, 463, 10.1038/386463a0 Stintzing, 2014, Clin. Cancer Res., 20, 3064, 10.1158/1078-0432.CCR-13-3175 Petroski, 2008, BMC Biochem., 9, S7, 10.1186/1471-2091-9-S1-S7 Chen, 2012, Curr. Cancer Drug Targets, 11, 239, 10.2174/156800911794519752 Zavrski, 2007, Recent Results Cancer Res., 176, 165, 10.1007/978-3-540-46091-6_14 Wang, 2013, Drug Metab. Dispos., 41, 230, 10.1124/dmd.112.047662 Beck, 2012, Biol. Chem., 393, 1101, 10.1515/hsz-2012-0212 Kisselev, 2008, Chem. Biol., 15, 419, 10.1016/j.chembiol.2008.04.010 Borissenko, 2007, Chem. Rev., 107, 687, 10.1021/cr0502504 Sterz, 2008, Expert Opin. Invest. Drugs, 17, 879, 10.1517/13543784.17.6.879 Tobinai, 2007, Int. J. Clin. Oncol., 12, 318, 10.1007/s10147-007-0695-5 Mateos, 2007, Best Pract. Res. Clin. Haematol., 20, 701, 10.1016/j.beha.2007.09.003 Kanagasabaphy, 2007, Curr. Opin. Invest. Drugs, 8, 447 Barr, 2007, Cancer Invest., 25, 766, 10.1080/07357900701579570 Vink, 2006, Br. J. Haematol., 134, 253, 10.1111/j.1365-2141.2006.06170.x Nau, 2008, Am. Fam. Physician, 78, 853 Radhakrishnan, 2010, Mol. Cell., 38, 17, 10.1016/j.molcel.2010.02.029 Schwartz, 2004, Oncology (Williston Park), 18, 14 Groll, 2009, J. Pept. Sci., 15, 58, 10.1002/psc.1107 Gallastegui, 2012, Angew. Chem. Int., Ed. Engl., 51, 247, 10.1002/anie.201106010 Beck, 2015, Angew. Chem. Int. Ed., Engl. Ozcan, 2013, J. Med. Chem., 56, 3783, 10.1021/jm400221d Lansdell, 2013, ACS Chem. Biol., 8, 578, 10.1021/cb300568r Azevedo, 2013, J. Med. Chem., 56, 5974, 10.1021/jm400235r Basse, 2010, J. Med. Chem., 53, 509, 10.1021/jm9011092 Hasegawa, 2014, Eur. J. Med. Chem., 71, 290, 10.1016/j.ejmech.2013.11.009 Ge, 2012, J. Med. Chem., 55, 1978, 10.1021/jm201118h Lawrence, 2010, Bioorg. Med. Chem., 18, 5576, 10.1016/j.bmc.2010.06.038 Kazi, 2009, Cell. Cycle, 8, 1940, 10.4161/cc.8.12.8798 Beck, 2015, Angew. Chem. Int., Ed. Engl., 54, 11275, 10.1002/anie.201505054 Gaczynska, 2014, Antioxid. Redox. Signal, 21, 2286, 10.1089/ars.2013.5816 Sprangers, 2008, Biochemistry, 47, 6727, 10.1021/bi8005913 Li, 2010, J. Natl. Cancer Inst., 102, 1069, 10.1093/jnci/djq198 de Wilt, 2012, Biochem. Pharmacol., 83, 207, 10.1016/j.bcp.2011.10.009 Huber, 2015, Structure Odom, 2015, Acc. Chem. Res. Dissanayake, 2012, Chem. Commun. (Camb.), 48, 440, 10.1039/C1CC15809K Swartz, 2011, Dalton Trans., 40, 7762, 10.1039/c1dt10127g Majumder, 2009, Org. Lett., 11, 4720, 10.1021/ol901855b Harris, 2001, Inorg. Chem., 40, 1987, 10.1021/ic001238r Shi, 2003, Chem. Commun. (Camb.), 586, 10.1039/b212423h Novak, 2002, Chem. Commun. (Camb.), 2796, 10.1039/b208751k Gaczynska, 2005, Methods Mol. Biol., 301, 3 Segel, 1975 Lee, 2009, Ann. Rheum. Dis., 68, 1761, 10.1136/ard.2008.097709 Nencioni, 2007, Leukemia, 21, 30, 10.1038/sj.leu.2404444 Tsukamoto, 2009, Expert Opin. Ther. Targets, 13, 605, 10.1517/14728220902866851 Napetschnig, 2013, Annu. Rev. Biophys., 42, 443, 10.1146/annurev-biophys-083012-130338 Sors, 2006, Blood, 107, 2354, 10.1182/blood-2005-06-2536 Gokel, 1976, Org. Synth., 55, 232 Li, 2010, Synthesis